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Background
Cardiovascular sequelae represent a leading cause of
mortality in Fabry disease. Early detection of cardiac
involvement is therefore a subject of considerable inter-
est. Low native T1 values have been shown to be asso-
ciated with echocardiographic markers of early systolic
and diastolic dysfunction, even in those without left ven-
tricular hypertrophy (LVH), and conceptually could be
used to optimise the efficacy of Enzyme replacement
therapy (ERT). The purpose of this study was to deter-
mine the relationship of both, native T1 and feature
tracking CMR (FT-CMR) derived strain parameters,
with maximal LV wall thickness and LVmass in Fabry’s
as a clinical marker of cardiac disease manifestation.
Methods
66 genetically confirmed successive Fabry patients (24 of
which ERT naïve, 3 male, 21 female) underwent CMR at
1.5T (Avanto, Siemens AG, Erlangen, Germany). A stan-
dardised clinical CMR protocol including T1 mapping
(Siemens Molli WIP 448) was used in all. A single ROI
was selected in the mid-wall of a basal and mid-short
axis slice, to determine a native T1 value, which was
then corrected for heart rate, and averaged. Global long-
itudinal (GLS) and circumferential strain (GCS) para-
meters were derived from 4-chamber and corresponding
mid-short axis SSFP cine images, using dedicated
CMR feature tracking software (Diogenes® TomTec,
Germany). Maximal wall thickness was determined from
the mid short axis slice, and LV mass was calculated
from the short axis stack (CMR Tools). Patients were
subdivided into two groups of normal LV mass and
increased LV mass.
Results
Baseline characteristics are shown in table 1. Basal T1
values were significantly lower in those with increased
LV mass compared to those with normal LV mass
(901 ± 36 ms vs. 951 ± 59 ms, p = 0.002, figure 1).
GLS was also seen to be reduced in this group (-14.1 ±
6.7 vs. -20.3 ± 3.7, p = 0.002). In those with normal LV
mass, T1 values were lower in males (924 ± 59 ms vs.
964 ± 55 ms, p = 0.03) whilst there was no significant
difference in GLS (-11.8 ± 5.7 vs. -16.4 ± 7.3, p = 0.669).
There was moderate negative correlation between LV
mass and basal T1 values (rs = -0.500, p < 0.0001), with
only mild positive correlation between mass and GLS
(rs = 0.348, p = 0.004). Native T1 values did not corre-
late with GLS (basal pre-contrast T1: rs = -0.203, p =
0.103). In those with normal LV mass, basal T1 values
correlated better with LV mass as compared to GLS (:
rs = -0.365, p = 0.009 and rs = -0.012, p = 0.932, respec-
tively), whereas the opposite was seen in those with
increased LV mass.
Conclusions
Native T1 mapping shows stronger correlation with
increased LV mass as compared to FT-MRI derived
longitudinal strain. It shows promise as a potential
future biomarker to detect early cardiac involvement in
Fabry disease, and potentially to guide patient selection
and timing of therapy.
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Table 1 Baseline Characteristics
Male (n = 24) Female (n = 42)
Age (years) 44.5 ± 13.5 45.9 ± 14.3 0.686
LV Mass BSA (g/m2) 98.8 ± 53.7 57.1 ± 18.3 0.001
Ejection Fraction (%) 66 ± 7 66 ± 8 0.794
Maximal Wall thickness (mm) 14.5 ± 6.8 9.6 ± 2.5 0.002
Systolic blood pressure (mmHg) 125.1 ± 12.5 119.7 ± 20.8 0.264
Diastolic blood pressure (mmHg) 72.5 ± 9.6 70.1 ± 12.7 0.436
Pre-contrast basal septal T1 (ms) 912 ± 53 954 ± 56 0.004
Pre-contrast mid septal T1 (ms) 915 ± 48 952 ± 52 0.007
Pre-contrast mean septal T1 (ms) 914 ± 48 953 ± 51 0.003
Global Longitudinal Strain (%) -16.3 ± 5.7 -20.2 ± 5.0 0.007
Global Circumferential Strain (%) -25.0 ± 4.9 -24.0 ± 5.2 0.49
Figure 1 Basal pre-contrast T1 values in LVH positive and
negative patients.
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